Matches in Wikidata for { <http://www.wikidata.org/entity/Q66072123> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66072123 description "assaig clínic" @default.
- Q66072123 description "clinical trial" @default.
- Q66072123 description "clinical trial" @default.
- Q66072123 description "clinical trial" @default.
- Q66072123 description "clinical trial" @default.
- Q66072123 description "ensaio clínico" @default.
- Q66072123 description "ensayo clínico" @default.
- Q66072123 description "ensayu clínicu" @default.
- Q66072123 description "essai clinique" @default.
- Q66072123 description "klinisch onderzoek" @default.
- Q66072123 description "клінічне випробування" @default.
- Q66072123 description "կլինիկական փորձարկում" @default.
- Q66072123 name "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 name "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 type Item @default.
- Q66072123 label "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 label "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 prefLabel "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 prefLabel "Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute" @default.
- Q66072123 P1132 Q66072123-250BD1AF-EC08-4342-B949-DAD7CFB0DD34 @default.
- Q66072123 P1476 Q66072123-12ABCD4C-0840-4E43-9279-5A2FB0124F64 @default.
- Q66072123 P17 Q66072123-A4387E3C-553E-4FFD-8EE8-4F80C95CC49A @default.
- Q66072123 P1813 Q66072123-5B08132A-F031-414F-92A1-B31812452D41 @default.
- Q66072123 P2899 Q66072123-2A04C5DA-9FB1-4E43-B93F-8F85350E31EC @default.
- Q66072123 P3098 Q66072123-2C8F8432-D581-4A99-AA7D-B4CFB6DDB511 @default.
- Q66072123 P31 Q66072123-6BB5F9D5-18DC-4472-B99F-2FE6499FC5C7 @default.
- Q66072123 P4135 Q66072123-0097FC8A-5738-4A51-BFEC-DC7585DC3FBF @default.
- Q66072123 P580 Q66072123-E5243B7A-2CF8-46F1-AF1F-EBCDA783CB92 @default.
- Q66072123 P582 Q66072123-7EFAE03A-8BDB-4C73-9E91-6F45518FB167 @default.
- Q66072123 P8363 Q66072123-840F5F75-7732-491E-8573-3AAD8C797885 @default.
- Q66072123 P1132 "+533" @default.
- Q66072123 P1476 "Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (Split Virion and Inactivated) Produced at Butantan Institute" @default.
- Q66072123 P17 Q155 @default.
- Q66072123 P1813 "FLU-05-IB" @default.
- Q66072123 P2899 "+6" @default.
- Q66072123 P3098 "NCT03057483" @default.
- Q66072123 P31 Q30612 @default.
- Q66072123 P4135 "+59" @default.
- Q66072123 P580 "2017-04-06T00:00:00Z" @default.
- Q66072123 P582 "2017-09-06T00:00:00Z" @default.
- Q66072123 P8363 Q818574 @default.